Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Evaluation of combinatorial vaccines against anthrax and plague in a murine model.

DuBois AB, Freytag LC, Clements JD.

Vaccine. 2007 Jun 11;25(24):4747-54. Epub 2007 Apr 20.


Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.


Protection against anthrax and plague by a combined vaccine in mice and rabbits.

Ren J, Dong D, Zhang J, Zhang J, Liu S, Li B, Fu L, Xu J, Yu C, Hou L, Li J, Chen W.

Vaccine. 2009 Dec 9;27(52):7436-41. doi: 10.1016/j.vaccine.2009.07.015. Epub 2009 Jul 25.


Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model.

Albrecht MT, Eyles JE, Baillie LW, Keane-Myers AM.

FEMS Immunol Med Microbiol. 2012 Aug;65(3):505-9. doi: 10.1111/j.1574-695X.2012.00974.x. Epub 2012 May 21.


Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens.

Glynn A, Freytag LC, Clements JD.

Vaccine. 2005 Mar 14;23(16):1957-65.


A parenteral DNA vaccine protects against pneumonic plague.

Yamanaka H, Hoyt T, Yang X, Bowen R, Golden S, Crist K, Becker T, Maddaloni M, Pascual DW.

Vaccine. 2010 Apr 19;28(18):3219-30. doi: 10.1016/j.vaccine.2010.02.022. Epub 2010 Mar 1.


A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague.

Yamanaka H, Hoyt T, Yang X, Golden S, Bosio CM, Crist K, Becker T, Maddaloni M, Pascual DW.

Infect Immun. 2008 Oct;76(10):4564-73. doi: 10.1128/IAI.00581-08. Epub 2008 Aug 11.


Effect of adjuvants and route of immunizations on the immune response to recombinant plague antigens.

Uddowla S, Freytag LC, Clements JD.

Vaccine. 2007 Nov 19;25(47):7984-93. Epub 2007 Oct 2.


Comparison of mouse, guinea pig and rabbit models for evaluation of plague subunit vaccine F1+rV270.

Qi Z, Zhou L, Zhang Q, Ren L, Dai R, Wu B, Wang T, Zhu Z, Yang Y, Cui B, Wang Z, Wang H, Qiu Y, Guo Z, Yang R, Wang X.

Vaccine. 2010 Feb 10;28(6):1655-60. doi: 10.1016/j.vaccine.2009.02.078. Epub 2009 Mar 9.


Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague.

Albrecht MT, Livingston BD, Pesce JT, Bell MG, Hannaman D, Keane-Myers AM.

Vaccine. 2012 Jul 6;30(32):4872-83. doi: 10.1016/j.vaccine.2012.04.078. Epub 2012 May 23.


Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.

Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR.

J Immunol. 2003 Jun 1;170(11):5636-43.


A comparison of non-toxin vaccine adjuvants for their ability to enhance the immunogenicity of nasally-administered anthrax recombinant protective antigen.

Gwinn WM, Johnson BT, Kirwan SM, Sobel AE, Abraham SN, Gunn MD, Staats HF.

Vaccine. 2013 Mar 1;31(11):1480-9. doi: 10.1016/j.vaccine.2013.01.012. Epub 2013 Jan 23.


Enhanced humoral and mucosal immune responses after intranasal immunization with chimeric multiple antigen peptide of LcrV antigen epitopes of Yersinia pestis coupled to palmitate in mice.

Uppada SB, Bhat AA, Sah A, Donthamshetty RN.

Vaccine. 2011 Nov 21;29(50):9352-60. doi: 10.1016/j.vaccine.2011.09.129. Epub 2011 Oct 12.


Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts.

Arlen PA, Singleton M, Adamovicz JJ, Ding Y, Davoodi-Semiromi A, Daniell H.

Infect Immun. 2008 Aug;76(8):3640-50. doi: 10.1128/IAI.00050-08. Epub 2008 May 27.


Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.

Sabhnani L, Manocha M, Sridevi K, Shashikiran D, Rayanade R, Rao DN.

FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):215-29.


An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model.

Williamson ED, Vesey PM, Gillhespy KJ, Eley SM, Green M, Titball RW.

Clin Exp Immunol. 1999 Apr;116(1):107-14.


Co-immunisation with a plasmid DNA cocktail primes mice against anthrax and plague.

Williamson ED, Bennett AM, Perkins SD, Beedham RJ, Miller J, Baillie LW.

Vaccine. 2002 Jul 26;20(23-24):2933-41.


Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice.

Flick-Smith HC, Eyles JE, Hebdon R, Waters EL, Beedham RJ, Stagg TJ, Miller J, Alpar HO, Baillie LW, Williamson ED.

Infect Immun. 2002 Apr;70(4):2022-8.

Supplemental Content

Support Center